Why Magna invests.
We empower companies to achieve their objectives.
We invest for impact, driven by the knowledge that our time, energy and capital is deployed not only to generate a return — but also to help our partners and portfolio companies achieve their objectives. This is our guiding principle. We are never prouder than when those that we’ve invested into tell us how much they’ve enjoyed their experiences with Magna — except when we see what they’re able to achieve with our support.
Magna was an early investor in Advaxis, today a $500 million biotechnology company developing the next generation of cancer immunotherapies, in partnership with pharmaceutical giants Merck, AstraZeneca and Incyte Corporation.
Magna was an early investor in Musclepharm, a small nutritional supplement company, now with an award-winning product line sold in over 120 countries and available in over 45,000 global retail outlets, including GNC, Vitamin Shoppe and Walmart.
Magna invested early in Terra Tech, a small agricultural company, which, by capitalizing on the growing cannabis market, is now considered one of the first companies poised to produce substantial revenue from the cultivation of medical marijuana.
PledgeMusic was founded by a team of musicians and entrepreneurs passionate about giving artists greater independence and fans more immersive musical connections. Today they’re redefining the way music gets made and building the world’s best direct-to-fan entertainment platform. With over 1,000,000 committed fans and thousands of artists, they’re clearly on to something.
In Fall 2014, Magna Ventures and Magna Entertainment came together to invest $2M of strategic capital into PledgeMusic, enabling the company to make key strategic hires and reinvigorate the brand and business as it entered 2015. Together with other strategic shareholders, and in partnership with the company’s Founders, Magna has taken an active role in supporting and accelerating their phenomenal mission.